Skip to main content

Health: Contaminated Blood Products

Volume 699: debated on Wednesday 20 February 2008

asked Her Majesty's Government:

Further to the Written Answer by Lord Darzi of Denham on 30 January (WA 127), whether they will apologise to NHS haemophilia patients for supplying contaminated blood products that infected them with HIV and hepatitis C, and to the dependants of the 1,757 who have died since being infected; and whether they will reach agreement with the haemophilia community to provide compensation for pain, suffering and deaths that ensued. [HL1840]

The Government deeply regret that patients with haemophilia were infected through contaminated blood products. We have great sympathy for patients who contracted HIV and or hepatitis C, and fully appreciate the hardship and pain experienced by families who cared for those who have died.

In 1988, the Macfarlane Trust was set up to administer a fund to assist people with haemophilia who had contracted HIV infection through contaminated blood products as a result of National Health Service treatment. In 2004, the Skipton Fund was established to administer an ex-gratia payment scheme for people infected with hepatitis C through contaminated blood or blood products following treatment on the NHS.